GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » Accounts Receivable

Sirnaomics (HKSE:02257) Accounts Receivable : HK$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Sirnaomics's accounts receivables for the quarter that ended in Dec. 2024 was HK$0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Sirnaomics's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 0.00.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Sirnaomics's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was HK$-1.36.


Sirnaomics Accounts Receivable Historical Data

The historical data trend for Sirnaomics's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirnaomics Accounts Receivable Chart

Sirnaomics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Receivable
Get a 7-Day Free Trial - - - - -

Sirnaomics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sirnaomics Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Sirnaomics Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Sirnaomics's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/13.821*91
=0.00

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Sirnaomics's accounts receivable are only considered to be worth 75% of book value:

Sirnaomics's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(91.485+0.75 * 0+0.5 * 0-344.618
-0--111.346)/104.343
=-1.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Sirnaomics Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Sirnaomics's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirnaomics Business Description

Traded in Other Exchanges
Address
No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN
Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.
Executives
Poon Hung Fai 2101 Beneficial owner
Lu Yang 2101 Beneficial owner
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Dai Xiaochang 2201 Interest of corporation controlled by you
Yan Xia Ling 2202 Interest of your spouse
Ceng Yu 2201 Interest of corporation controlled by you
Li Jie 2201 Interest of corporation controlled by you
Li Lele 2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp) 2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you

Sirnaomics Headlines

No Headlines